Physician profile
John R Steele
NPI 1881057131
$51,790.36
in general payments reported to CMS, 2019-2025
11 companies · $31K in 2025
The $31K reported for 2025 was more than what 85% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14K · 2023: $673 · 2024: $6,013 · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Food and Beverage: $2,280 · Travel and Lodging: $2,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,838.03 |
| Food and Beverage | $2,280.49 |
| Travel and Lodging | $2,061.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $32,256.81 | 2022-2025 | Velys, Actis, Attune |
| Smith+Nephew, INC. | $12,088.24 | 2022-2024 | Journey II, Legion Revision |
| Depuy Synthes Products, INC. | $5,644.37 | 2024 | |
| Depuy Synthes Sales INC. | $763.88 | 2022-2025 | Attune, Velys, Reclaim |
| Stryker Corporation | $557.85 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $163.65 | 2023 | Arista Ah Flexitip |
| Orthalign INC | $143.45 | 2022 | |
| Native Surgical, LLC | $79.92 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $51.77 | 2022-2024 | Zilretta, Iovera, Exparel |
| Ethicon US, LLC | $23.83 | 2023 | Stratafix, Dermabond Prineo |
| Zimmer Biomet Holdings, INC. | $16.59 | 2024 | Rosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.